RNA therapeutics bioanalysis

RNA therapeutics bioanalysis: quantification methods for siRNA and mRNA in preclinical PK studies and regulatory submissions

RNA therapeutics have moved from proof of concept to an established drug class in under a decade, with six approved siRNA drugs and multiple mRNA vaccines now on the market. Yet quantifying these molecules remains far from routine: oligonucleotide therapeutics…
Continue reading “RNA therapeutics bioanalysis: quantification methods for siRNA and mRNA in preclinical PK studies and regulatory submissions”…